Genetic Factors in Fetal Growth Restriction and Miscarriage

ABSTRACT

Recently, several investigations concerning disadvantageous genetic factors in human reproduction have progressed. Inherited thrombophilia, such as factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase mutations; gene polymorphisms of detoxification enzyme (CYP1A1); growth factors (insulin-like growth factor-I); and hormones such as angiotensinogen and CYP17 are involved in the pathogenesis of fetal growth restriction. The inherited thrombophilia, gene polymorphisms of coagulation and anticoagulation factor such as thrombomodulin, endothelial protein C receptor, plasminogen activator inhibitor 1, and factor XIII; human lymphocyte antigen (HLA-G); detoxification enzymes (glutathione-S-transferase M1); cytokines such as interleukin (IL) -1 and IL-6; hormones (CYP17); vasodilators (nitric oxide synthase 3); and vitamins (transcobalamin) are involved in the pathogenesis of sporadic and recurrent miscarriage. It is likely that a gene polymorphism or mutation susceptible to reproductive failure has a beneficial effect on the process of human reproduction with or without the environmental interaction. The factor V Leiden mutation has genetic advantages that are believed to be an improved implantation rate in in vitro fertilization and a reduction of maternal intrapartum blood loss. It has also been demonstrated that the CYP17 A2 allele has bidirectional effects on human reproduction, including increases in susceptibility to recurrent miscarriage and fetal growth enhancement.

KEYWORDS

Abortion - fetal growth restriction - genetic polymorphism - miscarriage

REFERENCES

• 1 Strauss R S. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort.  JAMA. 2000;  283 625-632
• 2 Gray P H, Jones P, O'Callaghan M J. Maternal antecedents for cerebral palsy in extremely preterm babies: a case-control study.  Dev Med Child Neurol. 2001;  43 580-585
• 3 Lundgren E M, Cnattingius S, Jonsson B, Tuvemo T. Intellectual and psychological performance in males born small for gestational age with and without catch-up growth.  Pediatr Res. 2001;  50 91-96
• 4 Barker D JP. Fetal programming and public health. In: O'Brien PMS, Wheeler T, Barker DJP Fetal Programming: Influences on Development and Disease in Later Life. London; RCOG Press 1999: 3-11
• 5 Johnstone F, Inglis L. Familial trends in low birth weight.  BMJ. 1974;  3 659-661
• 6 Khoury M J, Calle E E, Joesoef R M. Recurrence of low birth weight in siblings.  J Clin Epidemiol. 1989;  42 1171-1178
• 7 Magnus P, Bakketeig L S, Hoffman H. Birth weight of relatives by maternal tendency to repeat small-for-gestational-age (SGA) births in successive pregnancies.  Acta Obstet Gynecol Scand Suppl. 1997;  165 35-38
• 8 Bakketeig L S, Hoffman H J, Harley E E. The tendency to repeat gestational age and birth weight in successive births.  Am J Obstet Gynecol. 1979;  135 1086-1103
• 9 Hackman E, Emanuel I, van Belle G, Daling J. Maternal birth weight and subsequent pregnancy outcome.  JAMA. 1983;  250 2016-2019
• 10 Klebanoff M A, Graubard B I, Kessel S S, Berendes H W. Low birth weight across generations.  JAMA. 1984;  252 2423-2427
• 11 Klebanoff M A, Schulsinger C, Mednick B R, Secher N J. Preterm and small-for-gestational-age birth across generations.  Am J Obstet Gynecol. 1997;  176 521-526
• 12 Winkvist A, Mogren I, Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks.  Int J Epidemiol. 1998;  27 248-254
• 13 Warburton D, Fraser F C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit.  Am J Hum Genet. 1964;  16 1-25
• 14 Stephenson M D, Awartani K A, Robinson W P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study.  Hum Reprod. 2002;  17 446-451
• 15 Stirrat G M. Recurrent abortion. II. Clinical associations, causes, and management.  Lancet. 1990;  336 728-733
• 16 Parazzini F, Bocciolone L, Fedele L, Negri E, La Vecchia C, Acaia B. Risk factors for spontaneous abortion.  Int J Epidemiol. 1991;  20 157-161
• 17 Cramer D W, Wise L A. The epidemiology of recurrent pregnancy loss.  Semin Reprod Med. 2000;  18 331-339
• 18 Yamada H, Kato E H, Kobashi G et al.. Recurrent pregnancy loss: etiology of thrombophilia.  Semin Thromb Hemost. 2001;  27 121-129
• 19 Fenster L, Eskenazi B, Windham G C, Swan S H. Caffeine consumption during pregnancy and spontaneous abortion.  Epidemiology. 1991;  2 168-174
• 20 Kupferminc M J, Eldor A, Steinman N et al.. Increased frequency of genetic thrombophilia in women with complications of pregnancy.  N Engl J Med. 1999;  340 9-13
• 21 Kupferminc M J, Many A, Bar-Am A, Lessing J B, Ascher-Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia.  BJOG. 2002;  109 1373-1376
• 22 Martinelli P, Grandone E, Colaizzo D et al.. Familial thrombophilia and the occurrence of fetal growth restriction.  Haematologica. 2001;  86 428-431
• 23 Arias F, Romero R, Joist H, Kraus F T. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.  J Matern Fetal Med. 1998;  7 277-286
• 24 Many A, Schreiber L, Rosner S, Lessing J B, Eldor A, Kupferminc M J. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia.  Obstet Gynecol. 2001;  98 1041-1044
• 25 Peeters L L. Thrombophilia and fetal growth restriction.  Eur J Obstet Gynecol Reprod Biol. 2001;  95 202-205
• 26 Lindqvist P G, Svensson P J, Dahlback B, Marsal K. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss-a possible evolutionary selection mechanism.  Thromb Haemost. 1998;  79 69-73
• 27 Grandone E, Margaglione M, Colaizzo D et al.. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia.  Thromb Haemost. 1997;  77 1052-1054
• 28 Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.  J Med Genet. 1997;  34 525-526
• 29 Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.  Blood. 1996;  88 3698-3703
• 30 Rosendaal F R, Siscovick D S, Schwartz S M, Psaty B M, Raghunathan T E, Vos H L. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.  Blood. 1997;  90 1747-1750
• 31 Nebert D W, Gonzalez F J. P450 genes: structure, evolution and regulation.  Annu Rev Biochem. 1987;  56 945-993
• 32 Safe S H. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds.  Pharmacol Ther. 1995;  67 247-281
• 33 Harries L W, Stubbins M J, Forman D, Howard G C, Wolf C R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer.  Carcinogenesis. 1997;  18 641-644
• 34 Strange R C, Fryer A A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. In: Boffetta P, Caporaso N, Cuzick J, Lang M, Vineis P Metabolic Polymorphisms and Susceptibility to Cancer, Chapter 19. Lyon, France; IARC Scientific Publications, No. 148 1999: 231-249
• 35 Wang X, Zuckerman B, Pearson C et al.. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight.  JAMA. 2002;  287 195-202
• 36 Landi M T, Bertazzi P A, Shields P G et al.. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans.  Pharmacogenetics. 1994;  4 242-246
• 37 Pemble S, Schroeder K R, Spencer S R et al.. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism.  Biochem J. 1994;  300 271-276
• 38 Yamada H, Sata F, Kato E H et al.. polymorphism in the CYP17 gene and intrauterine fetal growth restriction.  Mol Hum Reprod. 2004;  10 49-53
• 39 Baranova H, Bothorishvilli R, Canis M et al.. Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population.  Mol Hum Reprod. 1997;  3 775-780
• 40 Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation.  Pediatr Res. 1991;  29 219-225
• 41 Giudice L C, de Zegher F, Gargosky S E et al.. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth.  J Clin Endocrinol Metab. 1995;  80 1548-1555
• 42 Leger J, Noel M, Limal J M, Czernichow P. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR.  Pediatr Res. 1996;  40 101-107
• 43 Liu J P, Baker J, Perkins A S, Robertson E J, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).  Cell. 1993;  75 59-72
• 44 Arends N, Johnston L, Hokken-Koelega A et al.. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA).  J Clin Endocrinol Metab. 2002;  87 2720-2724
• 45 Vaessen N, Janssen J A, Heutink P et al.. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight.  Lancet. 2002;  359 1036-1037
• 46 Hill D J, Petrik J, Arany E. Growth factors and the regulation of fetal growth.  Diabetes Care. 1998;  (suppl 2) B60-B69
• 47 Vaessen N, Heutink P, Janssen J A et al.. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction.  Diabetes. 2001;  50 637-642
• 48 Zhang X Q, Varner M, Dizon-Townson D, Song F, Ward K. A molecular variant of angiotensinogen is associated with idiopathic intrauterine growth restriction.  Obstet Gynecol. 2003;  101 237-242
• 49 Rotimi C, Cooper R, Ogunbiyi O et al.. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians.  Circulation. 1997;  95 2348-2350
• 50 Ward K, Hata A, Jeunemaitre X et al.. A molecular variant of angiotensinogen associated with preeclampsia.  Nat Genet. 1993;  4 59-61
• 51 Kobashi G, Hata A, Shido K et al.. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor.  Am J Med Genet. 1999;  86 232-236
• 52 Morgan T, Craven C, Nelson L, Lalouel J M, Ward K. Angiotensinogen T235 expression is elevated in decidual spiral arteries.  J Clin Invest. 1997;  100 1406-1415
• 53 Morgan T, Craven C, Lalouel J M, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua.  Am J Obstet Gynecol. 1999;  180 95-102
• 54 Loriaux D L, Ruder H J, Knab D R, Lipsett M B. Estrone sulfate, estrone, estradiol and estriol plasma levels in human pregnancy.  J Clin Endocrinol Metab. 1972;  35 887-891
• 55 Gerhard I, Fitzer C, Klinga K, Rahman N, Runnebaum B. Estrogen screening in evaluation of fetal outcome and infant’s development.  J Perinat Med. 1986;  14 279-291
• 56 Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D. Tobacco smoking, pregnancy estrogens, and birth weight.  Epidemiology. 1990;  1 247-250
• 57 Markestad T, Bergsjo P, Aakvaag A et al.. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.  Acta Obstet Gynecol Scand. 1997;  165(suppl) 50-55
• 58 Gardner M O, Goldenberg R L, Cliver S P et al.. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation.  Acta Obstet Gynecol Scand. 1997;  165(suppl) 56-58
• 59 Peck J D, Hulka B S, Savitz D A, Baird D, Poole C, Richardson B E. Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy.  Am J Epidemiol. 2003;  157 258-266
• 60 Salas S P, Rosso P, Espinoza R, Robert J A, Valdes G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation.  Obstet Gynecol. 1993;  81 1029-1033
• 61 Picado-Leonard J, Miller W L. Cloning and sequence of the human gene for P450c17 (steroid 17 α-hydroxylase/17,20 lyase): similarity with the gene for P450c21.  DNA. 1987;  6 439-448
• 62 Carey A H, Waterworth D, Patel K et al.. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 .  Hum Mol Genet. 1994;  3 1873-1876
• 63 Feigelson H S, Shames L S, Pike M C, Coetzee G A, Stanczyk F Z, Henderson B E. Cytochrome P450c17αgene (CYP17) polymorphism is associated with serum oestrogen and progesterone concentration.  Cancer Res. 1998;  58 585-587
• 64 Haiman C A, Hankinson S E, Spiegelman D et al.. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.  Cancer Res. 1999;  59 1015-1020
• 65 Bukovsky A, Cekanova M, Caudle M R et al.. Expression and localization of estrogen receptor-alpha protein in normal and abnormal term placentae and stimulation of trophoblast differentiation by estradiol.  Reprod Biol Endocrinol. 2003;  1 13
• 66 Gorai I, Tanaka K, Inada M et al.. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women.  J Clin Endocrinol Metab. 2003;  88 799-803
• 67 Feigelson H S, Coetzee G A, Kolonel L N, Ross R K, Henderson B E. A polymorphism in the CYP17 gene increases the risk of breast cancer.  Cancer Res. 1997;  57 1063-1065
• 68 Bergman-Jungestrom M, Gentile M, Lundin A C, Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women.  Int J Cancer. 1999;  84 350-353
• 69 Spurdle A B, Hopper J L, Dite G S et al.. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.  J Natl Cancer Inst. 2000;  92 1674-1681
• 70 Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women.  Eur J Cancer. 2000;  36 2375-2379
• 71 Rey E, Kahn S R, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis.  Lancet. 2003;  361 901-908
• 72 Franchi F, Biguzzi E, Cetin I et al.. Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss.  Br J Haematol. 2001;  114 641-646
• 73 Gu J M, Crawley J T, Ferrell G et al.. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality.  J Biol Chem. 2002;  277 43335-43343
• 74 Lee N, Malacko A R, Ishitani A et al.. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.  Immunity. 1995;  3 591-600
• 75 Lee N, Goodlett D R, Ishitani A, Marquardt H, Geraghty D E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.  J Immunol. 1998;  160 4951-4960
• 76 Colonna M, Samaridis J, Cella M et al.. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.  J Immunol. 1998;  160 3096-3100
• 77 Lopez-Botet M, Navarro F, Llano M. How do NK cells sense the expression of HLA-G class Ib molecules?.  Semin Cancer Biol. 1999;  9 19-26
• 78 Le Gal F A, Riteau B, Sedlik C et al.. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes.  Int Immunol. 1999;  11 1351-1356
• 79 Kapasi K, Albert S E, Yie S, Zavazava N, Librach C L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.  Immunology. 2000;  101 191-200
• 80 Moreau P, Adrian-Cabestre F, Menier C et al.. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes.  Int Immunol. 1999;  11 803-811
• 81 Le Bouteiller P, Solier C, Proll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: where and what for?.  Hum Reprod Update. 1999;  5 223-233
• 82 Ober C, Aldrich C L, Chervoneva I et al.. Variation in the HLA-G promoter region influences miscarriage rates.  Am J Hum Genet. 2003;  72 1425-1435
• 83 Allen R H, Stabler S P, Savage D G, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.  FASEB J. 1993;  7 1344-1353
• 84 Steegers-Theunissen R P, Boers G H, Trijbels F J, Eskes T K. Neural-tube defects and derangement of homocysteine metabolism.  N Engl J Med. 1991;  324 199-200
• 85 Mills J L, McPartlin J M, Kirke P N et al.. Homocysteine metabolism in pregnancies complicated by neural-tube defects.  Lancet. 1995;  345 149-151
• 86 Steegers-Theunissen R P, Boers G H, Blom H J, Trijbels F J, Eskes T K. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae.  Lancet. 1992;  339 1122-1123
• 87 Wouters M G, Boers G H, Blom H J et al.. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss.  Fertil Steril. 1993;  60 820-825
• 88 Nelen W L, Blom H J, Steegers E A, den Heijer M, Eskes T K. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis.  Fertil Steril. 2000;  74 1196-1199
• 89 Afman L A, Van Der Put N M, Thomas C M, Trijbels J M, Blom H J. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects.  Q J Med. 2001;  94 159-166
• 90 Namour F, Guy M, Aimone-Gastin I, de Nonancourt M, Mrabet N, Gueant J L. Isoelectrofocusing phenotype and relative concentration of transcobalamin II isoproteins related to the codon 259 Arg/Pro polymorphism.  Biochem Biophys Res Commun. 1998;  251 769-774
• 91 Gardiki-Kouidou P, Seller M J. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects.  Clin Genet. 1988;  33 441-448
• 92 Magnus P, Magnus E M, Berg K. Transcobalamins in the etiology of neural tube defects.  Clin Genet. 1991;  39 309-310
• 93 Zetterberg H, Regland B, Palmer M et al.. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion.  Hum Reprod. 2002;  17 3033-3036
• 94 Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M et al.. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.  Clin Chem. 2003;  49 1081-1086
• 95 Pfeiffer K A, Fimmers R, Engels G, van der Ven H, van der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion.  Mol Hum Reprod. 2001;  7 373-378
• 96 Aldrich C L, Stephenson M D, Karrison T et al.. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage.  Mol Hum Reprod. 2001;  7 1167-1172
• 97 Rebmann V, Passler M, Erhard J, Lange R, Eigler F W, Grosse-Wilde H. Monitoring of soluble HLA class I size variants after liver transplantation.  Hum Immunol. 1999;  60 424-429
• 98 Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles.  Tissue Antigens. 2001;  57 15-21
• 99 Hayes J D, Strange R C. Glutathione S-transferase polymorphisms and their biological consequences.  Pharmacology. 2000;  61 154-166
• 100 Strange R C, Jones P W, Fryer A A. Glutathione S-transferase: genetics and role in toxicology.  Toxicol Lett. 2000;  112-113 357-363
• 101 Ketterer B, Meyer D J. Glutathione transferases: a possible role in the detoxication and repair of DNA and lipid hydroperoxides.  Mutat Res. 1989;  214 33-40
• 102 Harris C C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s.  Cancer Res. 1991;  51(suppl) 5023-5044
• 103 Nebert D W. Role of genetics and drug metabolism in human cancer risk.  Mutat Res. 1991;  247 267-281
• 104 Sata F, Yamada H, Kondo T et al.. Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss.  Mol Hum Reprod. 2003;  9 165-169
• 105 Hirvonen A, Taylor J A, Wilcox A et al.. Xenobiotic metabolism genes and the risk of recurrent spontaneous abortion.  Epidemiology. 1996;  7 206-208
• 106 Mendola P, Moysich K B, Freudenheim J L et al.. Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTM1.  Epidemiology. 1998;  9 666-668
• 107 Zusterzeel P L, Nelen W L, Roelofs H M, Peters W H, Blom H J, Steegers E A. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss.  Mol Hum Reprod. 2000;  6 474-478
• 108 Baranov V S, Ivaschenko T, Bakay B et al.. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases.  Hum Genet. 1996;  97 516-520
• 109 Baranova H, Bothorishvilli R, Canis M et al.. Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population.  Mol Hum Reprod. 1997;  3 775-780
• 110 Baranova H, Canis M, Ivaschenko T et al.. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis.  Mol Hum Reprod. 1999;  5 636-641
• 111 Mosmann T R, Coffman R L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties.  Annu Rev Immunol. 1989;  7 145-173
• 112 Krishnan L, Guilbert L J, Wegmann T G, Belosevic M, Mosmann T R. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.  J Immunol. 1996;  156 653-662
• 113 Wegmann T G, Lin H, Guilbert L, Mosmann T R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?.  Immunol Today. 1993;  14 353-356
• 114 Lin H, Mosmann T R, Guilbert L, Tuntipopipat S, Wegmann T G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface.  J Immunol. 1993;  151 4562-4573
• 115 Wang Z C, Yunis E J, De los Santos M J, Xiao L, Anderson D J, Hill J A. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region.  Genes Immun. 2002;  3 38-42
• 116 Hefler L A, Tempfer C B, Bashford M T et al.. Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1beta gene promoter in women with idiopathic recurrent miscarriage.  Mol Hum Reprod. 2002;  8 95-100
• 117 Reid J G, Simpson N A, Walker R G et al.. The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss.  Am J Reprod Immunol. 2001;  45 35-40
• 118 Hefler L A, Tempfer C B, Unfried G et al.. A polymorphism of the interleukin-1beta gene and idiopathic recurrent miscarriage.  Fertil Steril. 2001;  76 377-379
• 119 Karhukorpi J, Laitinen T, Kivela H, Tiilikainen A, Hurme M. IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion.  J Reprod Immunol. 2003;  58 61-67
• 120 Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber J C. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage.  Fertil Steril. 2001;  75 683-687
• 121 Saijo Y, Sata F, Yamada H, Kondo T, Kato E H, Kishi R. Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss.  Fertil Steril. 2004;  81 374-378
• 122 Wolff M V, Thaler C J, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion.  Mol Hum Reprod. 2000;  6 627-634
• 123 Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions.  Hum Reprod. 2000;  15 2011-2017
• 124 Koumantaki Y, Matalliotakis I, Sifakis S et al.. Detection of interleukin-6, interleukin-8, and interleukin-11 in plasma from women with spontaneous abortion.  Eur J Obstet Gynecol Reprod Biol. 2001;  98 66-71
• 125 Ota N, Nakajima T, Nakazawa I et al.. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.  J Hum Genet. 2001;  46 267-272
• 126 Fishman D, Faulds G, Jeffery R et al.. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.  J Clin Invest. 1998;  102 1369-1376
• 127 Unfried G, Bocskor S, Endler G, Nagele F, Huber J C, Tempfer C B. A polymorphism of the interleukin-6 gene promoter and idiopathic recurrent miscarriage.  Hum Reprod. 2003;  18 267-270
• 128 Lim C S, Zheng S, Kim Y S et al.. The-174 G to C polymorphism of interleukin-6 gene is very rare in Koreans.  Cytokine. 2002;  19 52-54
• 129 Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani D C. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population.  Pharmacogenetics. 2001;  11 699-701
• 130 Sata F, Yamada H, Yamada A et al.. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.  Mol Hum Reprod. 2003;  9 725-728
• 131 Weston A, Pan C F, Bleiweiss I J et al.. CYP17 genotype and breast cancer risk.  Cancer Epidemiol Biomarkers Prev. 1998;  7 941-944
• 132 Helzlsouer K J, Huang H Y, Strickland P T et al.. Association between CYP17 polymorphisms and the development of breast cancer.  Cancer Epidemiol Biomarkers Prev. 1998;  7 945-949
• 133 Nakajin S, Shinoda M, Haniu M, Shively J E, Hall P F. C21 steroid side chain cleavage enzyme from porcine adrenal microsomes: purification and characterization of the 17αhydroxylase/C17,20-lyase cytochrome P450.  J Biol Chem. 1984;  259 3971-3976
• 134 Voutilainen R, Miller W L. Developmental expression of genes for steroidogenic enzymes P450scc (20,22-desmolase), P450c17 (17α-hydroxylase/17,20 lyase), and P450c21 (21-hydroxylase) in the human fetus.  J Clin Endocrinol Metab. 1986;  63 1145-1150
• 135 Kristensen V N, Haraldsen E K, Anderson K B et al.. CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1.  Cancer Res. 1999;  59 2825-2828
• 136 Li T C, Spuijbroek M D, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage.  BJOG. 2000;  107 1471-1479
• 137 Tempfer C, Moreno R M, O'Brien W E, Gregg A R. Genetic contributions of the endothelial nitric oxide synthase gene to ovulation and menopause in a mouse model.  Fertil Steril. 2000;  73 1025-1031
• 138 Tsukada T, Yokoyama K, Arai T et al.. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans.  Biochem Biophys Res Commun. 1998;  245 190-193
• 139 Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F, Huber J C. Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage.  Hum Reprod. 2001;  16 1644-1647
• 140 Kobashi G, Yamada H, Ohta K, Kato E, Ebina Y, Fujimoto S. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy.  Am J Med Genet. 2001;  103 241-244
• 141 Miyata T, Kawasaki T, Fujimura H, Uchida K, Tsushima M, Kato H. The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals.  Blood Coagul Fibrinolysis. 1998;  9 451-452
• 142 Kobashi G, Yamada H, Asano T et al.. The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan.  Semin Thromb Hemost. 1999;  25 487-489
• 143 Gopel W, Ludwig M, Junge A K, Kohlmann T, Diedrich K, Moller J. Selection pressure for the factor-V-Leiden mutation and embryo implantation.  Lancet. 2001;  358 1238-1239